COVID-19 Scan for Sep 20, 2022

Fallout continues over Biden’s ‘pandemic is over’ feedback

At a routine press briefing right this moment, two White Home officers fielded questions on President Joe Biden’s current off-the-cuff remark throughout a information program that the pandemic is over, whereas acknowledging that COVID remains to be an issue.

When a reporter requested if Biden would carry the “pandemic is over” message to the world stage in his deal with tomorrow on the United Nations Basic Meeting, Jake Sullivan, Biden’s Nationwide Safety Advisor, mentioned Biden will inform world leaders that the core purpose is to be higher ready for the subsequent pandemic, equivalent to finalizing a funding facility on the World Financial institution, enhancing vaccine manufacturing functionality throughout a wider vary of areas, and needing to be taught classes from COVID-19 to keep away from repeating errors.

Journalists additionally requested Biden’s press secretary, Karine Jean-Pierre, in regards to the president’s feedback and a letter from Sen. Richard Burr, R-North Carolina, the rating member of the Senate Well being, Schooling, Labor, and Pensions (HELP) committee that juxtaposes the feedback with the necessity to lengthen the well being emergency and add extra funding. She mentioned Biden was clear within the interview that COVID stays an issue.

“What he believes is we will acknowledge the large quantity of progress that we’ve got made,” she mentioned. “Now we’re in a spot the place it’s way more manageable.”

Jean-Pierre additionally pressed Congress to approve funding to raised put together the nation to reply for future threats from COVID and different epidemics.
Sep 20 White Home press briefing
Sep 19 Burr letter obtained by CNN
Sep 19 CIDRAP Information story

Helmet-style oxygenation did not decrease dying charge in extreme COVID-19

Noninvasive air flow delivered via an oxygen helmet did not considerably decrease 28-day dying charges amongst grownup COVID-19 pneumonia sufferers with respiratory failure past that of masks, high-flow nasal cannulas, or different commonplace strategies, however interpretation of the outcomes was restricted by an imprecise impact estimate, finds a randomized, managed trial in Saudi Arabia and Kuwait.

The analysis, printed right this moment in JAMA, concerned 187 males and 133 ladies with respiratory failure on account of COVID-19 pneumonia randomly assigned to obtain supplemental oxygen via both a helmet or a masks, high-flow nasal cannula, or different commonplace strategies at eight websites from Feb 8 to Nov 16, 2021. Some sufferers had each therapies for a time due to medical necessity. Median affected person age was 58 years.

The researchers famous that helmet air flow has been utilized in COVID-19 sufferers underneath the premise that it’s higher in a position to ship extended oxygen due to fewer air leaks, improved match, and fewer danger of pores and skin stress harm, eye irritation, and aerosol technology, though supporting knowledge in COVID-19 sufferers are missing.

At 28 days, 27.0% of 159 sufferers assigned to the helmet group died, in contrast with 26.1% of the 161 standard-care sufferers, a statistically nonsignificant distinction. A complete of 47.2% of the helmet group wanted endotracheal intubation, in contrast with 50.3% within the standard-care group (relative danger, 0.94; 95% confidence interval, 0.75 to 1.17).

Barotrauma, or tissue harm associated to stress variations inside and out of doors the physique, occurred in 18.9% of the helmet group and 15.5% of the standard-care group. A complete of three.1% of the helmet group and 6.2% of standard-care sufferers skilled skin-pressure harm. One and two severe adversarial occasions occurred within the standard-care and helmet teams, respectively.

Helmet air flow has been used for 20 years in some nations, the authors mentioned, and in March 2020 the US Meals and Drug Administration approved it for COVID-19 sufferers with respiratory failure.

Though helmets did not seem to confer a survival benefit, due to limitations equivalent to a small pattern dimension and unblinded therapy allocation, the researchers mentioned that they can not exclude potential scientific profit or hurt.
Sep 20 JAMA study



Leave a Reply